NCT03064282View on ClinicalTrials.gov

Prostatic Hyperplasia Treatment and Cancer Prevention

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 1, 2021

Conditions
Prostatic Hyperplasia
Interventions
OTHER

Placebo

observation of skin changes if any

DRUG

papaverine

observation of symptoms

Sponsors
All Listed Sponsors
lead

Manchanda Medical Clinic

OTHER